Reference
Sawada M, et al. Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nab-paclitaxel therapy in metastatic pancreatic cancer. BMC Cancer 20: 20 May 2020. Available from: URL: http://doi.org/10.1186/s12885-020-06945-8
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1811, 42 (2020). https://doi.org/10.1007/s40278-020-80265-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-80265-y